ADMA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 3.70%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $9,613,370.88

ADMA Biologics Insider Trading History Chart

ADMA Biologics Share Price & Price History

^$19.43

▼ -0.415 (-2.09%)

As of 04/1/2025 04:25 PM ET

Days: 30 | 90 | 365

ADMA Biologics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/22/2024	Brad L. Tade	CFO	Sell	15,000	$21.15	$317,250.00	199,433
9/9/2024	Lawrence P. Guiheen	Director	Sell	9,000	$18.47	$166,230.00	153,941
8/30/2024	Kaitlin M Kestenberg-Messina	COO	Sell	24,150	$16.90	$408,135.00	449,088
8/29/2024	Jerrold B. Grossman	Director	Sell	136,861	$17.27	$2,363,589.47	467,305
8/26/2024	Adam S. Grossman	CEO	Sell	236,889	$17.69	$4,190,566.41	2,059,726
8/23/2024	Young Kwon	Director	Sell	60,000	$18.26	$1,095,600.00	241,441
6/14/2024	Adam S. Grossman	CEO	Sell	100,000	$10.72	$1,072,000.00	2,081,475
3/18/2024	Steve Elms	Director	Sell	49,887	$6.01	$299,820.87	2,527,500
3/15/2024	Steve Elms	Director	Sell	183,008	$6.01	$1,099,878.08	2,577,387
3/13/2024	Steve Elms	Director	Sell	407,000	$6.21	$2,527,470.00	3,208,671
8/30/2023	Jerrold B. Grossman	Director	Buy	130,000	$3.71	$482,300.00	443,265
8/24/2023	Young Kwon	Director	Buy	25,000	$3.90	$97,500.00	277,401
8/22/2023	Bryant Fong	Director	Sell	1,433,304	$3.87	$5,546,886.48	59,901
8/18/2023	Adam S. Grossman	CEO	Sell	250,000	$4.15	$1,037,500.00	2,273,085
8/15/2023	Adam S. Grossman	CEO	Sell	510,469	$4.54	$2,317,529.26	4,113,075
8/15/2023	Brian Lenz	CFO	Sell	211,578	$4.60	$973,258.80	782,013
12/9/2022	Adam S. Grossman	CEO	Buy	14,983	$2.86	$42,851.38	2,203,708
12/9/2022	Brian Lenz	CFO	Buy	6,993	$2.86	$19,999.98	1,034,825

See Full Table

SEC Filings (Institutional Ownership Changes) for ADMA Biologics (NASDAQ:ADMA)

75.68% of ADMA Biologics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

ADMA Biologics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/24/2025	Wellington Management Group LLP	105,459	$1.81M	0.0%	-11.6%	0.045%
3/18/2025	California State Teachers Retirement System	217,391	$3.73M	0.0%	+4.2%	0.092%
2/25/2025	Heck Capital Advisors LLC	13,123	$0.23M	0.0%	N/A	0.006%
2/25/2025	B. Riley Wealth Advisors Inc.	12,614	$0.22M	0.0%	-31.8%	0.005%
2/20/2025	Mackenzie Financial Corp	74,539	$1.28M	0.0%	+212.2%	0.032%
2/19/2025	GF Fund Management CO. LTD.	4,964	$85K	0.0%	N/A	0.002%
2/18/2025	Neo Ivy Capital Management	297,627	$5.10M	1.0%	+512.6%	0.126%
2/18/2025	Palisades Investment Partners LLC	400,663	$6.87M	2.9%	+14.8%	0.169%
2/18/2025	AWM Investment Company Inc.	2,426,431	$41.61M	5.1%	-45.5%	1.026%
2/18/2025	Castleark Management LLC	386,366	$6.63M	0.2%	-44.2%	0.163%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	511,526	$8.77M	0.0%	+0.3%	0.216%
2/17/2025	Virtus Fund Advisers LLC	3,021	$52K	0.2%	-71.2%	0.001%
2/17/2025	Virtus Investment Advisers Inc.	14,980	$0.26M	0.2%	-80.8%	0.006%
2/17/2025	Twinbeech Capital LP	214,710	$3.68M	0.1%	N/A	0.091%
2/17/2025	Two Sigma Advisers LP	2,950,124	$50.60M	0.1%	-33.8%	1.248%
2/17/2025	Two Sigma Investments LP	2,548,954	$43.72M	0.1%	-29.0%	1.078%
2/17/2025	Tidal Investments LLC	30,351	$0.52M	0.0%	-20.8%	0.013%
2/17/2025	Stonepine Capital Management LLC	1,241,032	$21.28M	17.2%	-33.6%	0.525%
2/17/2025	Tang Capital Management LLC	550,000	$9.43M	0.6%	N/A	0.233%
2/17/2025	Sherbrooke Park Advisers LLC	20,066	$0.34M	0.1%	+43.9%	0.008%
2/17/2025	Rafferty Asset Management LLC	513,128	$8.80M	0.0%	+31.2%	0.217%
2/17/2025	Point72 Asset Management L.P.	212,326	$3.64M	0.0%	+91.3%	0.090%
2/17/2025	ProShare Advisors LLC	79,286	$1.36M	0.0%	+30.2%	0.034%
2/17/2025	Man Group plc	745,300	$12.78M	0.0%	+305.5%	0.315%
2/17/2025	Nicholas Investment Partners LP	177,382	$3.04M	0.3%	-37.5%	0.075%
2/17/2025	Nuveen Asset Management LLC	4,552,317	$78.07M	0.0%	-30.8%	1.926%
2/17/2025	Miura Global Management LLC	50,000	$0.86M	0.9%	+25.0%	0.021%
2/17/2025	Morse Asset Management Inc	7,300	$0.13M	0.0%	+3,144.4%	0.003%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	148,638	$2.56M	0.0%	+7.2%	0.063%
2/17/2025	Lazard Asset Management LLC	348,599	$5.98M	0.0%	+38.4%	0.147%
2/17/2025	Janus Henderson Group PLC	107,161	$1.84M	0.0%	+16.3%	0.045%
2/17/2025	Gotham Asset Management LLC	166,694	$2.86M	0.0%	+1.3%	0.071%
2/17/2025	Graham Capital Management L.P.	11,726	$0.20M	0.0%	N/A	0.005%
2/17/2025	Ensign Peak Advisors Inc	65,550	$1.12M	0.0%	N/A	0.028%
2/17/2025	D. E. Shaw & Co. Inc.	3,066,575	$52.59M	0.0%	-41.7%	1.297%
2/17/2025	Deutsche Bank AG	3,875,708	$66.47M	0.0%	-6.2%	1.640%
2/17/2025	Driehaus Capital Management LLC	1,371,207	$23.52M	0.2%	-33.3%	0.580%
2/17/2025	CoreCap Advisors LLC	39,915	$0.69M	0.0%	+13.7%	0.017%
2/17/2025	Cubist Systematic Strategies LLC	384,076	$6.59M	0.0%	+3,269.1%	0.162%
2/17/2025	Cetera Investment Advisers	49,841	$0.86M	0.0%	-10.9%	0.021%
2/17/2025	Centiva Capital LP	17,337	$0.30M	0.0%	N/A	0.007%
2/17/2025	Bosun Asset Management LLC	64,470	$1.11M	0.5%	-15.4%	0.027%
2/17/2025	Caxton Associates LP	51,568	$0.88M	0.0%	-32.0%	0.022%
2/17/2025	Bellevue Group AG	16,900	$0.29M	0.0%	-34.7%	0.007%
2/17/2025	Bank of America Corp DE	766,224	$13.14M	0.0%	+59.7%	0.324%
2/17/2025	BNP Paribas Financial Markets	76,772	$1.32M	0.0%	-89.8%	0.032%
2/17/2025	Ameriprise Financial Inc.	715,672	$12.27M	0.0%	+14.1%	0.303%
2/17/2025	Algert Global LLC	272,349	$4.67M	0.1%	+33.3%	0.115%
2/14/2025	Freestone Grove Partners LP	44,816	$0.77M	0.0%	N/A	0.019%
2/14/2025	AQR Capital Management LLC	530,168	$9.09M	0.0%	-10.0%	0.224%
2/14/2025	Northern Trust Corp	2,575,075	$44.16M	0.0%	+6.0%	1.089%
2/14/2025	The Manufacturers Life Insurance Company	120,612	$2.07M	0.0%	-4.8%	0.051%
2/14/2025	Oxford Asset Management LLP	13,420	$0.23M	0.1%	N/A	0.006%
2/14/2025	Virtus ETF Advisers LLC	18,728	$0.32M	0.1%	-38.7%	0.008%
2/14/2025	Lord Abbett & CO. LLC	2,207,277	$37.86M	0.1%	-28.7%	0.934%
2/14/2025	Oberweis Asset Management Inc.	3,342,560	$57.33M	2.7%	+15.0%	1.414%
2/14/2025	Voya Investment Management LLC	918,361	$15.75M	0.0%	+46.8%	0.388%
2/14/2025	Harvest Investment Services LLC	125,867	$2.16M	0.5%	+40.1%	0.053%
2/14/2025	Massar Capital Management LP	74,339	$1.28M	1.4%	N/A	0.031%
2/14/2025	Hsbc Holdings PLC	29,736	$0.51M	0.0%	+38.0%	0.013%
2/14/2025	B Group Inc.	2,287,542	$39.23M	24.0%	N/A	0.968%
2/14/2025	State of Tennessee Department of Treasury	105,482	$1.81M	0.0%	+25.4%	0.045%
2/14/2025	Teachers Retirement System of The State of Kentucky	72,100	$1.24M	0.0%	+37.6%	0.031%
2/14/2025	Tower Research Capital LLC TRC	39,236	$0.67M	0.0%	+1,029.7%	0.017%
2/14/2025	MetLife Investment Management LLC	136,212	$2.34M	0.0%	+4.7%	0.058%
2/14/2025	Mesirow Institutional Investment Management Inc.	782,451	$13.42M	1.0%	-21.9%	0.331%
2/14/2025	BI Asset Management Fondsmaeglerselskab A S	110,063	$1.89M	0.0%	N/A	0.047%
2/14/2025	Dimensional Fund Advisors LP	4,668,320	$80.07M	0.0%	+16.0%	1.975%
2/14/2025	First Trust Advisors LP	333,309	$5.72M	0.0%	-40.6%	0.141%
2/14/2025	GeoWealth Management LLC	37,224	$0.64M	0.0%	-10.4%	0.016%
2/14/2025	Altium Capital Management LLC	1,395,000	$23.92M	6.8%	+2.6%	0.590%
2/13/2025	CANADA LIFE ASSURANCE Co	276,571	$4.74M	0.0%	-1.4%	0.117%
2/13/2025	Zacks Investment Management	254,662	$4.37M	0.0%	-11.6%	0.108%
2/13/2025	EAM Global Investors LLC	277,151	$4.75M	0.9%	-31.4%	0.117%
2/13/2025	EAM Investors LLC	235,813	$4.04M	0.6%	-13.5%	0.100%
2/13/2025	Jump Financial LLC	23,504	$0.40M	0.0%	N/A	0.010%
2/13/2025	Guggenheim Capital LLC	67,778	$1.16M	0.0%	+528.9%	0.029%
2/13/2025	XTX Topco Ltd	23,107	$0.40M	0.0%	N/A	0.010%
2/13/2025	Mariner LLC	33,419	$0.57M	0.0%	N/A	0.014%
2/13/2025	Barclays PLC	541,093	$9.28M	0.0%	+2.4%	0.229%
2/13/2025	Summit Investment Advisors Inc.	23,560	$0.40M	0.4%	+3.3%	0.010%
2/13/2025	Covestor Ltd	5,996	$0.10M	0.1%	+7,038.1%	0.003%
2/13/2025	Kennedy Capital Management LLC	269,652	$4.63M	0.1%	-30.3%	0.114%
2/13/2025	LSV Asset Management	80,300	$1.38M	0.0%	-35.4%	0.034%
2/13/2025	Raymond James Financial Inc.	1,112,275	$19.08M	0.0%	N/A	0.471%
2/13/2025	Renaissance Technologies LLC	3,769,888	$64.65M	0.1%	+2.8%	1.595%
2/13/2025	Legal & General Group Plc	836,850	$14.35M	0.0%	+20.1%	0.354%
2/13/2025	Invesco Ltd.	11,296,255	$193.73M	0.0%	-10.5%	4.779%
2/13/2025	Bank of Montreal Can	26,562	$0.46M	0.0%	-98.7%	0.011%
2/13/2025	Cerity Partners LLC	43,128	$0.76M	0.0%	-15.2%	0.018%
2/13/2025	Federated Hermes Inc.	1,306,936	$22.41M	0.0%	-19.7%	0.553%
2/13/2025	Russell Investments Group Ltd.	646,009	$11.08M	0.0%	-20.1%	0.273%
2/13/2025	Envestnet Asset Management Inc.	60,004	$1.03M	0.0%	+68.0%	0.025%
2/13/2025	Aviva PLC	31,427	$0.54M	0.0%	N/A	0.013%
2/13/2025	Wells Fargo & Company MN	250,561	$4.30M	0.0%	-61.3%	0.106%
2/13/2025	Integrated Quantitative Investments LLC	77,266	$1.33M	0.7%	N/A	0.033%
2/12/2025	ExodusPoint Capital Management LP	102,351	$1.76M	0.0%	N/A	0.043%
2/12/2025	Trexquant Investment LP	34,434	$0.59M	0.0%	-95.8%	0.015%
2/12/2025	Geode Capital Management LLC	5,432,384	$93.19M	0.0%	+0.9%	2.298%
2/12/2025	Franklin Resources Inc.	327,011	$5.61M	0.0%	+95.1%	0.138%

Data available starting January 2016

See Full Table

ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, it operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.

Today's Range

Now: $19.43

$19.15

$19.91

50 Day Range

MA: $17.21

$15.44

$20.61

52 Week Range

Now: $19.43

$5.89

$23.64

Volume

1,332,204 shs

Average Volume

2,728,189 shs

Market Capitalization

$4.59 billion

P/E Ratio

69.38

Dividend Yield

N/A

Beta

0.6

Who are the company insiders with the largest holdings of ADMA Biologics?: ADMA Biologics' top insider investors include:
Adam S Grossman (CEO)
Steve Elms (Director)
Brian Lenz (CFO)
Jerrold B Grossman (Director)
Kaitlin M Kestenberg-Messina (COO)
Young Kwon (Director)
Brad L Tade (CFO)
Lawrence P Guiheen (Director)
Bryant Fong (Director)
Learn More about top insider investors at ADMA Biologics.
Who are the major institutional investors of ADMA Biologics?: ADMA Biologics' top institutional shareholders include:
Vanguard Group Inc. — 7.70%
Invesco Ltd. — 4.78%
Geode Capital Management LLC — 2.30%
Dimensional Fund Advisors LP — 1.97%
Nuveen Asset Management LLC — 1.93%
Deutsche Bank AG — 1.64%
Learn More about top institutional investors of ADMA Biologics stock.
Which institutional investors are selling ADMA Biologics stock?: Within the last quarter, ADMA stock was sold by these institutional investors:
Assenagon Asset Management S.A.
D. E. Shaw & Co. Inc.
Bank of Montreal Can
AWM Investment Company Inc.
Nuveen Asset Management LLC
Two Sigma Advisers LP
Invesco Ltd.
Two Sigma Investments LP
Within the previous year, company insiders that have sold ADMA Biologics company stock include:
Adam S Grossman (CEO)
Steve Elms (Director)
Brian Lenz (CFO)
Jerrold B Grossman (Director)
Kaitlin M Kestenberg-Messina (COO)
Young Kwon (Director)
Learn More investors selling ADMA Biologics stock.
Which institutional investors are buying ADMA Biologics stock?: Within the previous quarter, ADMA stock was acquired by institutional investors including:
Perpetual Ltd
Allspring Global Investments Holdings LLC
B Group Inc.
Raymond James Financial Inc.
Raymond James Financial Inc.
Arrowstreet Capital Limited Partnership
Dimensional Fund Advisors LP
Susquehanna International Group LLP
During the previous year, these company insiders have bought ADMA Biologics stock:
Adam S Grossman (CEO)
Steve Elms (Director)
Learn More investors buying ADMA Biologics stock.